|  Help  |  About  |  Contact Us

Publication : GARP regulates the bioavailability and activation of TGFβ.

First Author  Wang R Year  2012
Journal  Mol Biol Cell Volume  23
Issue  6 Pages  1129-39
PubMed ID  22278742 Mgi Jnum  J:197004
Mgi Id  MGI:5490445 Doi  10.1091/mbc.E11-12-1018
Citation  Wang R, et al. (2012) GARP regulates the bioavailability and activation of TGFbeta. Mol Biol Cell 23(6):1129-39
abstractText  Glycoprotein-A repetitions predominant protein (GARP) associates with latent transforming growth factor-beta (proTGFbeta) on the surface of T regulatory cells and platelets; however, whether GARP functions in latent TGFbeta activation and the structural basis of coassociation remain unknown. We find that Cys-192 and Cys-331 of GARP disulfide link to the TGFbeta1 prodomain and that GARP with C192A and C331A mutations can also noncovalently associate with proTGFbeta1. Noncovalent association is sufficiently strong for GARP to outcompete latent TGFbeta-binding protein for binding to proTGFbeta1. Association between GARP and proTGFbeta1 prevents the secretion of TGFbeta1. Integrin alpha(V)beta(6) and to a lesser extent alpha(V)beta(8) are able to activate TGFbeta from the GARP-proTGFbeta1 complex. Activation requires the RGD motif of latent TGFbeta, disulfide linkage between GARP and latent TGFbeta, and membrane association of GARP. Our results show that GARP is a latent TGFbeta-binding protein that functions in regulating the bioavailability and activation of TGFbeta.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Bio Entities

Trail: Publication

0 Expression